Cargando…
Memantine ameliorates cognitive deficit in AD mice via enhancement of entorhinal–CA1 projection
BACKGROUND: Memantine, a low- to moderate-affinity uncompetitive N-methyl-D-aspartate receptor antagonist, has been shown to improve cognitive functions in animal models of Alzheimer’s disease (AD). Here we treated APP/PS1 AD mice with a therapeutic dose of memantine (20 mg/kg/day) and examined its...
Autores principales: | Li, Peng, Xu, Jin, Gu, Huanhuan, Peng, Hua, Yin, You, Zhuang, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201811/ https://www.ncbi.nlm.nih.gov/pubmed/34120588 http://dx.doi.org/10.1186/s12868-021-00647-y |
Ejemplares similares
-
Memantine Ameliorates Migraine Headache
por: Shanmugam, Sundar, et al.
Publicado: (2019) -
Suppression of exaggerated NMDAR activity by memantine treatment ameliorates neurological and behavioral deficits in aminopeptidase P1-deficient mice
por: Bae, Young-Soo, et al.
Publicado: (2022) -
DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice
por: Arsenault, Dany, et al.
Publicado: (2011) -
Chronic Memantine Treatment Ameliorates Behavioral Deficits, Neuron Loss, and Impaired Neurogenesis in a Model of Alzheimer’s Disease
por: Stazi, Martina, et al.
Publicado: (2020) -
Naringin ameliorates cognitive deficits in streptozotocin-induced diabetic rats
por: Liu, Xianchu, et al.
Publicado: (2016)